Skip to main content
. Author manuscript; available in PMC: 2013 May 20.
Published in final edited form as: J Immunol Methods. 2008 Nov 17;340(2):144–153. doi: 10.1016/j.jim.2008.10.013

Table 1.

Summary of numbers of clones and positive rates for screening/verification at each step of anti-TLR scFv generation.

Screened by Initial Screen - Raw Phage Fingerprint Purified phage Binding to cells scFv binding to cells

# of clones screened # of clones positive # of unique clones # of clones positive # of clones positive
hTLR2 HEK 168 78 (46%) 9/23 (39%) 8/9 (89%) 5/5 (100%)

mTLR2-HEK 84 43 (51%) 18/32 (56%) 5/9 (56%) 5/5 (100%)

hTLR5-HEK R3 186 39 (21%) 18/39 (46%) 2/17 (12%) 1/2 (50%)

 R4* 92 22 (24%) 2/19 (11%) 1/2 (50%) 1/2 (50%)

hTLR6-HEK 186 11 (6%) 6/8 (75%) 1/6 (17%) 1/1 (100%)

hTLR1-HEK 94 0 (0%) N/A N/A N/A

Numbers in fractions indicate “number of positive clones/number of clones tested” and percentages in parentheses indicate positive rates for each test.

*

Results after performing a 4th round of selection (R4) for hTLR5 versus the standard 3 rounds (R3) of selection.